Caremark | Jotup

Berger Montague Announces that its False Claims Act Whistleblower Case Against CVS Health Will Move Forward to Trial

Retrieved on:

Thursday, April 4, 2024

Element, Employment, CVS Caremark, CVS, Rite Aid, Accusative case, Federation, District court, Pharmacy, False Claims Act, CVS Health, Fraud, Caremark, Multimedia, Medicare, Government, Court, PBM, Pharmaceutical industry

PHILADELPHIA, April 4, 2024 /PRNewswire/ -- Berger Montague PC is pleased to announce that its False Claims Act whistleblower case against CVS Caremark Corp. (including its pharmacy benefit manager subsidiary, CVS Caremark) for false drug pricing to Medicare will move forward to trial.

Key Points:

PHILADELPHIA, April 4, 2024 /PRNewswire/ -- Berger Montague PC is pleased to announce that its False Claims Act whistleblower case against CVS Caremark Corp. (including its pharmacy benefit manager subsidiary, CVS Caremark) for false drug pricing to Medicare will move forward to trial.
The case is brought under the False Claims Act which allows private individuals to bring claims on behalf of the government to recover for fraud against the government.
In its summary judgment decision, the Court rejected the CVS Health defendants' attempt to have the claims dismissed without trial.
We are very pleased with the Court's ruling and look forward to presenting our case to a jury at trial," said Sorensen.

Local Pharmacies on the Brink, New Survey Reveals

Retrieved on:

Tuesday, February 27, 2024

Pharmacy, DIR, CMS, Part, Thought, Sale, MBA, Letter, Pharmacist, Hardship, Human, Medicare, Patient, Tax, Express Scripts, Medicare Part D, CVS, NCPA, Congress, PBM, Caremark, Community, CBO, Prescription, Insurance, Pressure, Health insurance

The rule is intended to give pharmacies and patients more transparency on drug pricing.

Key Points:

The rule is intended to give pharmacies and patients more transparency on drug pricing.
According to the new NCPA survey, 32 percent of all respondents say they are considering closing their doors in 2024 because of the cash crunch.
Increased vertical and horizontal consolidation of PBMs and health plans has caused severe inequities to pharmacies and Medicare Part D beneficiaries alike.
Community pharmacies are rooted in the communities where they are located and are among America’s most accessible health care providers.

Hagens Berman Sobol Shapiro LLP Announce a Class Action Which May Affect You If You Had A Health Plan That Paid for Generic Prescription Drugs Purchased at CVS Pharmacy

Retrieved on:

Friday, November 10, 2023

Defendant, Court order, Express Scripts, Pharmacy, Medco, UnitedHealth Group, L.L.C, District court, Local, CLASS, HSP, Court, CVS, CVS Pharmacy, Caremark, PBM, ACTION

prescription drugs purchased at CVS Pharmacy, a

Key Points:

prescription drugs purchased at CVS Pharmacy, a
class action lawsuit could affect your rights.
A CLASS ACTION LAWSUIT is pending in the U.S. District Court for the District of Rhode Island (the "Court").
Class Plaintiffs contend that they were overcharged for the generic drugs in the HSP program as a result of Defendants' actions.
The complete class definitions are available in the LONG-FORM NOTICE on the website www.CVSHSPClassAction.com or by contacting the Notice Administrator.

Payback Time! Community Pharmacists Cheer Class Action Lawsuit Against PBMs to Recoup DIR Fees

Retrieved on:

Wednesday, September 27, 2023

“Finally, community pharmacies have a chance to recover DIR fees that were unfairly taken.

Key Points:

“Finally, community pharmacies have a chance to recover DIR fees that were unfairly taken.
That allows Caremark and the other PBMs to continue to treat pharmacies unfairly and illegally extract junk fees.
We’re thrilled that community pharmacists have a chance to recoup some of their money.”
NCPA will be doing more than cheerleading for the lawsuit, said Hoey.
Community pharmacies are rooted in the communities where they are located and are among America’s most accessible health care providers.

Federman & Sherwood Announces Investigation into Claims that CVS Has Lied to Oklahomans About Their Prescriptions

Retrieved on:

Tuesday, April 25, 2023

Class Action Lawsuit, Professional Services, Legal, Caremark, CVS, Insurance, Oklahoma Insurance Commissioner, Pharmacy, Prescription, Letter, Sherwood, Keystone State Park (Oklahoma), Pharmacy benefit management, CVS Caremark, Dietary supplement

Federman & Sherwood announces investigation into claims that CVS has lied to Oklahomans about their prescriptions.

Key Points:

Federman & Sherwood announces investigation into claims that CVS has lied to Oklahomans about their prescriptions.
As part of a settlement with the Oklahoma Insurance Commissioner, CVS Caremark was to write to its customers and explain the State of Oklahoma had not outlawed long-term prescription refills as CVS had previously told them.
Insurance Commissioner Glen Mulready said the company, rather than clarify, just spread more misinformation with its latest round of correspondence.
If you received a letter and want to discuss this action, please contact:
View source version on businesswire.com: https://www.businesswire.com/news/home/20230425006142/en/

Labor Law Attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, File Suit, Against Caremark, L.L.C. for Allegedly Failing to Provide Employees With Accurate Wages

Retrieved on:

Tuesday, April 18, 2023

LLP, Superior court, Policy, COVID-19, California Labor Code, San Bernardino County Superior Court, Complaint, Supreme court, Ridesharing, Private investigator, Caremark, L.L.C

SAN BERNARDINO, Calif., April 18, 2023 /PRNewswire-PRWeb/ -- The Los Angeles employment law attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, filed a class action lawsuit against Caremark, L.L.C. alleging the company violated the California Labor Code. The lawsuit against Caremark, L.L.C. is currently pending in the San Bernardino County Superior Court, Case No. CIVSB2227033. To read a copy of the Complaint, please click here.

Key Points:

allegedly failed to accurately record employees' hours worked, which allegedly resulted in missed minimum and overtime wages.
SAN BERNARDINO, Calif., April 18, 2023 /PRNewswire-PRWeb/ -- The Los Angeles employment law attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP , filed a class action lawsuit against Caremark, L.L.C.
Blumenthal Nordrehaug Bhowmik De Blouw LLP is a labor law firm with law offices located in San Diego County, Riverside County, Los Angeles County, Sacramento County, Santa Clara County, Orange County, and San Francisco County.
Nicholas De Blouw, Blumenthal Nordrehaug Bhowmik De Blouw LLP, (800) 568-8020, [email protected]

REID COLLINS & TSAI LLP RECOVERS $175 MILLION SETTLEMENT FROM FORMER INSYS DIRECTORS IN OPIOID-RELATED LAWSUIT

Retrieved on:

Friday, April 14, 2023

National trial firm Reid Collins & Tsai LLP represents Insys Liquidation Trust in lawsuit against former directors of Insys Therapeutics, a public company which played a key role in the national opioid crisis.

Key Points:

National trial firm Reid Collins & Tsai LLP represents Insys Liquidation Trust in lawsuit against former directors of Insys Therapeutics, a public company which played a key role in the national opioid crisis.
Settlement terms include $175 million judgment against the former directors, partial payment from their personal assets, and assignment of their claims to recover the balance from insurance companies.
AUSTIN, Texas, April 14, 2023 /PRNewswire/ -- Today, national trial firm Reid Collins & Tsai LLP ("Reid Collins") representing the Insys Liquidation Trust (the "Trust") announced a $175 million settlement agreement with certain former directors of Insys Therapeutics, Inc. ("Insys"), partially resolving civil litigation arising from its bankruptcy case.
Insys, a former public company, marketed and sold a highly addictive and inherently dangerous fentanyl spray to millions of people.

Connecteam Brings Its All-in-One Workforce Management App to UK Care Week

Retrieved on:

Tuesday, March 14, 2023

Connecteam , the all-in-one platform to empower and engage workers whose jobs are not performed at a desk, will be at UK Care Week March 22-23, 2023.

Key Points:

Connecteam , the all-in-one platform to empower and engage workers whose jobs are not performed at a desk, will be at UK Care Week March 22-23, 2023.
The workforce management app enables healthcare organizations to seamlessly manage and communicate with their frontline staff, fostering a more collaborative work environment that helps increase engagement and retention.
The work is physically and emotionally demanding, and the remote nature of home healthcare can make carers feel especially isolated.
Its ease of use and secure platform enabled us to implement the app quickly with rapid adoption across teams and employees.

New Drug Channels Institute Study Analyzes Impact of Inflation Reduction Act on U.S. Prescription Market

Retrieved on:

Tuesday, March 14, 2023

PHILADELPHIA, March 14, 2023 /PRNewswire-PRWeb/ -- Today, Drug Channels Institute (DCI) released its exclusive, in-depth analysis of U.S. pharmacies and pharmacy benefit managers (PBMs). The new 2023 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers provides the most comprehensive, fact-based tool for understanding the entire U.S. drug pricing, reimbursement, and dispensing system.

Key Points:

"Beginning this year, the Inflation Reduction Act of 2022 (IRA) will alter many crucial aspects of the Medicare Part D program and the overall drug channel," says Drug Channels Institute CEO Adam J. Fein, Ph.D., the study's author and a widely regarded expert on pharmaceutical economics and the drug distribution system.
"This legislation will impact the vertically integrated organizations that dominate many aspects of U.S. drug market.
In 2022, total prescription dispensing revenues of retail, mail, long-term care, and specialty pharmacies reached $550 billion," Fein adds.
"However, the rapid expansion of patient-paid prescriptions—via cash-pay pharmacies and discount card vendors—is transforming the generic prescription market."

Custom Health Names James M. Sweeney as its Newest Director

Retrieved on:

Thursday, January 26, 2023

Medicine, Pharmacist, Growth, Population health, Caremark, Transitional care, Patient, Acquisition, New Bridge Medical Center, Philips, Nursing

MOUNTAIN VIEW, Calif., Jan. 26, 2023 /PRNewswire/ -- Custom Health, a leading provider of integrated digital healthcare solutions, today announced the addition of James M. Sweeney to the Custom Health Board of Directors.

Key Points:

MOUNTAIN VIEW, Calif., Jan. 26, 2023 /PRNewswire/ -- Custom Health, a leading provider of integrated digital healthcare solutions, today announced the addition of James M. Sweeney to the Custom Health Board of Directors.
"We are delighted to have James join us," said Rahul Chopra, Custom Health CEO.
"With his remarkable track record, visionary mindset and focus on growth, we are confident he will help Custom Health achieve new heights.
Custom Health ensures patients stay on track with their medications and makes it more likely that medicines perform as prescribers intend.